Cytokinetics | Muscle Biology Therapies

cardiovascular disease

Cardiovascular diseases are the leading cause of death in the U.S. and in many places around the world. We’re focused on finding potential treatments for people with heart failure and hypertrophic cardiomyopathy.

NEUROMUSCULAR DISEASE

Neuromuscular diseases can cause loss of muscle function, muscle weakness and fatigue. Our goal is develop potential therapies for people with amyotrophic lateral sclerosis and spinal muscular atrophy.

Press Releases

April 8, 2020Cytokinetics to Participate in the 19th Annual Needham Virtual Healthcare Conference
March 30, 2020Correction: Cytokinetics Announces Baseline Characteristics from GALACTIC-HF at ACC.20/WCC Virtual
March 20, 2020Cytokinetics to Announce Baseline Characteristics from GALACTIC-HF During ACC.20/WCC

view all

Corporate Presentation

Download

Pipeline

We have robust pipeline of small molecule muscle activators and inhibitors, including omecamtiv mecarbil, reldesemtiv, CK-274, AMG 594 and CK-601.

Careers

We seek exceptional individuals to join us in our mission to develop the next generation of novel small molecule muscle-directed potential medicines.